Last reviewed · How we verify
Phenocoll (phenamine)
Phenocoll (generic name: phenamine) is a drug. It is currently in unknown development.
Phenocoll works by interacting with a specific target in the body to produce a therapeutic effect.
Phenocoll (phenamine) is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not known whether it is FDA approved or off-patent. There is limited information available on its approved indications, half-life, and bioavailability. Further research is needed to understand its mechanism of action and key safety considerations. As a result, it is difficult to provide a comprehensive summary of this drug.
At a glance
| Generic name | phenamine |
|---|---|
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Unfortunately, the exact mechanism of action of phenocoll is not well understood, and more research is needed to determine how it produces its effects. In general, small molecule drugs like phenocoll work by binding to a specific protein or receptor in the body, which can alter the way that cells function and communicate with each other. This can lead to changes in various physiological processes, such as the regulation of chemical signals or the contraction of muscles.
Approved indications
Common side effects
Key clinical trials
- tTIS Targeted of the Striatum as an Intervention for MUD Patients (NA)
- The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine (PHASE4)
- A Trial to Assess How Centanafadine Interacts With Stimulants in the Body (PHASE1)
- Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users (PHASE2)
- Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b) (PHASE2,PHASE3)
- Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: PRE-FAIR (NA)
- Vyvanse in Children Aged 6 to 12 Years (EARLY_PHASE1)
- Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phenocoll CI brief — competitive landscape report
- Phenocoll updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Phenocoll
What is Phenocoll?
How does Phenocoll work?
What is the generic name of Phenocoll?
What development phase is Phenocoll in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing